Seres Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	83	142	144	189	701	765
Market Cap Growth	-34.79%	-1.09%	-23.96%	-73.04%	-8.39%	-65.84%
Enterprise Value	116.96	169.01	195.94	254.29	678.44	517.33
Last Close Price	8.66	14.88	16.62	28.00	112.00	166.60
PE Ratio	13.56	23.25	-	-1.58	-2.42	-11.57
PS Ratio	101.09	180.23	-	-	-	5.28
PB Ratio	1.80	3.22	10.43	-4.21	65.03	5.82
P/TBV Ratio	1.74	2.99	9.37	-3.99	56.13	5.81
P/FCF Ratio	92.21	164.39	-0.96	-1.51	-2.94	-265.96
P/OCF Ratio	71.40	127.31	-0.97	-1.61	-3.06	114.45
EV/Sales Ratio	148.24	214.21	-	-	-	3.57
EV/EBITDA Ratio	-	-1.88	-1.69	-1.35	-3.60	-8.84
EV/EBIT Ratio	-	-1.80	-1.62	-1.30	-3.48	-8.02
EV/FCF Ratio	135.21	195.39	-1.32	-2.03	-2.84	-179.75
Debt / Equity Ratio	1.64	1.64	6.02	-4.31	14.70	0.32
Debt / EBITDA Ratio	-0.92	-0.92	-0.79	-1.05	-0.86	-0.84
Debt / FCF Ratio	95.91	95.91	-0.61	-1.59	-0.68	-17.10
Net Debt / Equity Ratio	0.84	0.84	4.41	-1.58	-1.74	-1.84
Net Debt / EBITDA Ratio	-0.41	-0.41	-0.52	-0.37	0.10	4.13
Net Debt / FCF Ratio	43.01	43.01	-0.41	-0.56	0.08	83.91
Asset Turnover	0.01	0.01	0	0	0	0.42
Quick Ratio	2.40	2.40	0.80	1.30	2.12	3.53
Current Ratio	2.56	2.56	0.94	1.78	2.28	3.69
Return on Equity (ROE)	19.64%	19.64%	809.55%	1116.02%	-267.24%	-42.83%
Return on Assets (ROA)	-67.60%	-67.60%	-48.68%	-55.16%	-55.45%	-18.48%
Return on Invested Capital (ROIC)	-117.49%	-117.49%	-86.36%	-132.43%	-408.64%	-168.82%
Return on Capital Employed (ROCE)	-86.43%	-86.43%	-67.67%	-74.59%	-72.83%	-22.66%
Earnings Yield	7.14%	4.30%	0.00%	-63.46%	-41.25%	-8.64%
FCF Yield	1.08%	0.61%	-103.63%	-66.29%	-34.03%	-0.38%
Buyback Yield / Dilution	-14.15%	-14.15%	-21.40%	-18.44%	-17.86%	-14.93%
Total Shareholder Return	-14.15%	-14.15%	-21.40%	-18.44%	-17.86%	-14.93%

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q